Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Seminars in Cell and Developmental Biology Année : 2021

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases

Résumé

Sphingolipids are complex lipids. They play a structural role in neurons, but are also involved in regulating cellular communication, and neuronal differentiation and maturation. There is increasing evidence to suggest that dysregulated metabolism of sphingolipids is linked to neurodegenerative processes in amyotrophic lateral sclerosis (ALS), Parkinson's disease and Gaucher's disease. In this review, we provide an overview of the role of sphingolipids in the development and maintenance of the nervous system. We describe the implications of altered metabolism of sphingolipids in the pathophysiology of certain neurodegenerative diseases, with a primary focus on ALS. Finally, we provide an update of potential treatments that could be used to target the metabolism of sphingolipids in neurodegenerative diseases.
Fichier principal
Vignette du fichier
1-s2.0-S1084952120301038-main.pdf (2.39 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03376327 , version 1 (13-10-2021)

Identifiants

Citer

Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Bradley Turner, et al.. Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Seminars in Cell and Developmental Biology, 2021, 112, pp.82-91. ⟨10.1016/j.semcdb.2020.10.008⟩. ⟨inserm-03376327⟩

Collections

INSERM SITE-ALSACE
14 Consultations
76 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More